Futura Medical Share Discussion Threads

[lbo] 13/12/2022 11:49

Still no attempt to explain how a company can expect to enforce a patent on something that was clearly already well described in research literature!?https://www.londonstockexchange.com/news-article/FUM/update-on-positive-eu-regulatory-discussions/14421486'The Company has conducted initial literature and in vitro based research that has shown the cooling from the evaporation of these specific combinations of solvents'https://www.edisoninvestmentresearch.com/?ACT=18&ID=10479There is a risk that some claims will either be challenged in future (eg on the grounds of non-obviousness or existence of prior art) and/or that another technology may be employed to achieve a similar effect. The protracted development times mean the clock has been ticking on the original issued patents, reducing the protected commercial productshttps://www.medisca.com/Pages/ProductDetails.aspx?StockCode=2258&C=B&C2=109A smooth gel intended for alcohol soluble actives. Provides cooling effect upon application while leaving minimal residuehttps://www.gskhealthpartner.com/content/dam/cf-consumer-healthcare/health-professionals/en_IN/pdf/article-1.pdfThe cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results.

[lbo] 13/12/2022 11:46

Oh and there are Carbopol alternatives on the market so a competitor can still create a cooling gel similar to Med3000 with all the same ingredients of water, alcohol, gycol and carbopol.







177 days is all it will take to a have similar product on the market via the 510k pathway of Med3000 is registered as a De Novo medical device. No clinical studies required for similar alcohol, water and glycol gels claiming to treat ED with evaporative cooling. And remember Futura still haven’t t even shown that evaporative cooling or needing a cabopol excipient to make the gel feel nicer is what is having any effect! LOL



˜There is no evidence for the evaporative mode of action from the clinical trials. To show that the evaporation is what makes MED3000 work, you'd need to compare it to a non-evaporative gel’



˜This De Novo authorization will also allow subsequent devices of the same type and intended use to come to the market through the 510k pathway, which could enable the devices to get on the market faster’

De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk devices of a new type. Along with this De Novo authorization, the FDA is establishing criteria called special controls that define the requirements related to labeling and performance testing. When met, the special controls, in combination with general controls, provide a reasonable assurance of safety and effectiveness for devices of this type. This action also creates a new regulatory classification, which means that subsequent devices of the same type with the same intended use may go through the FDA 510(k) pathway, whereby devices can obtain clearance by demonstrating substantial equivalence to a predicate device

The average length of time for clearance under the traditional 510(k) pathway is 177 days,



a company must compare their product to one already cleared by the FDA and provide evidence that their product is substantially equivalent to the previously cleared (legally marketed) device. To be substantially equivalent, the product must meet criteria for the same intended use, have the same technology or (slightly) different technology but produces similar end results, and be safe and effective. Once pre-market clearance is received from the FDA the device can be distributed commercially immediately

[j777j] 13/12/2022 11:44

Current av price target is around 100p Both brokers talk of upgrades as news develops and i see 150p/180p as their next levels.Fantastic news from the company.2023 will have made all this waiting worthwhile

[petroc] 13/12/2022 11:15

Panic time for LiarBO and all other stock bashers! Come on LiarBO, keep your nonsense about everything except MED3000 coming - it's giving us all a good laugh watching you struggle!

[broomrigg] 13/12/2022 10:40

Little attempt at a tree shake this morning by the market but persistant buying has kicked in again.....11th BLUE DAY in a row.

[lbo] 13/12/2022 09:22

For many, whether or not placebo use is ethical depends partly on whether patients are being deceived and whether there is a known better treatment.
A clinician who doesn’t deceive a patient, and who provides a placebo for something for which there is no known treatment, such as irritable bowel syndrome, might be ethically OK, says Jeremy Howick, of the Department of Primary Health Care Sciences, at the University of Oxford, and lead author of the Plos One study. But there is no evidence that this company is enhancing care. What they’ve been doing is completely unethical



Could a 'Placebo' Become the Next Big ED Treatment?

not everyone is ready to jump on the bandwagon

[petroc] 13/12/2022 09:21

If there is a placing it might be a chance for LiarBO to get some in, if he had any money. Unfortunately he lost it all when he gambled on CSD500, which is why he keeps going on about it. Never mind, LiarBO, just sit back and watch this share price rocket! Alternatively, pay attention to all the REAL rampers who are coming on board now and copy/paste your rubbish frantically in a desperate attempt to hold back the tide. I wonder which course you'll steer? Hahaha, you ain't going to stop stock bashing after 5 years wasted on it, are you, you sad individual!

[j777j] 13/12/2022 09:19

As previously reported in September 2022, the first production order of Eroxon(R) has been received to enable initial launches through its European & UK distribution partner, Cooper Consumer Health and the planned debut of Eroxon(R) remains on track. In addition, we are also pleased to announce that the first production order for initial launches of Eroxon(R) in the Middle East, which are planned for 2023, has been agreed through our distribution partner Labatec Pharma.




Its green for go!

[lbo] 13/12/2022 09:19

Yes any placebo arousal gel/cooling lubricant could be used as the first line treatment for Psychogenic ED after all organic causes have been fully ruled out!The question is could a patient sue a physician for not informing them it was a placebo!

[j777j] 13/12/2022 09:16

The AIM-listed company said the search for a US commercial partner has begun and its corporate advisors are engaged in “a number” of ongoing discussions.



Bidding war for the massive US market has begun

[j777j] 13/12/2022 09:13

According to leading ED expert Eroxon could be use as a first line treatment

[j777j] 13/12/2022 08:22

MED3000 commercialisation and launch plans

In the past 18 months, Futura entered into and signed multiple commercial agreements throughout the European Economic Area, the United Kingdom, the Gulf Co-operation Council (GCC) region, Switzerland and South Korea. The Company is continuing to expand its strong network of licensing and distribution partners as it moves towards initial launches of MED3000 in the first half of 2023.

In line with the Board's US commercialisation strategy following the successful completion of FM71 and the FDA dossier submission in October 2022, Futura's corporate advisors have formally commenced the search for a US commercial partner and are engaged in a number of ongoing discussions. The Company looks forward to providing a further update in due course.

As previously reported in September 2022, the first production order of Eroxon(R) has been received to enable initial launches through its European & UK distribution partner, Cooper Consumer Health and the planned debut of Eroxon(R) remains on track. In addition, we are also pleased to announce that the first production order for initial launches of Eroxon(R) in the Middle East, which are planned for 2023, has been agreed through our distribution partner Labatec Pharma.

[broomrigg] 13/12/2022 08:05

Don't miss out folks, revenue streams are very close now...these are cheap as chips at 50p.